Fisher on the CAC 40
This ranking weighs Revenue growth ×4, Analyst upside ×3, Buy % ×2, Gross margin ×2, and nothing else, across the 38 companies we track on the CAC 40. Fisher set no numeric limits at all, so no company here is ever flagged: his fifteen points are qualitative.
Ranked highest by Fisher on this market right now, which is not the same list as the one that clears the limits above:
- EssilorLuxottica (EL.PA) · Healthcare · Revenue growth 5.7% · Analyst upside 62.9% · Buy % 83% · Gross margin 60%
- STMicroelectronics (STMPA.PA) · Technology · Revenue growth 26.1% · Analyst upside 50.1% · Buy % 62% · Gross margin 34%
- Capgemini (CAP.PA) · Technology · Revenue growth 8.8% · Analyst upside 38.9% · Buy % 71% · Gross margin 27%
- Sanofi (SAN.PA) · Healthcare · Revenue growth 14.6% · Analyst upside 27.2% · Buy % 48% · Gross margin 73%
- Safran (SAF.PA) · Industrials · Revenue growth 16.0% · Analyst upside 18.2% · Buy % 68% · Gross margin 47%
From data as of 2026-09-11 05:01:01 UTC. Rebuilt every hour; the table above is live.